Danimer Scientific, Inc. DNMR
Set alert
At close · Dec 30
- YTD
- -83.33%
- 1 year
- -91.53%
- Open
- 0.35
- Prev close
- 0.35
- Mkt cap
- 11.51M
- Vol
- 128.42K
- Avg vol
- 64.37K
- EPS
- -40.40
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.325
- High
- 1.13
- Forward P/E
- -8.11
- Beta
- 1.63
- Short ratio
- 33.63
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 9.50
- 200-d avg
- 22.42
- 1y target
- 4.67
2Y chart
Events in this range
- Mar 28, 2024Earnings: —; estimate -15.6; surprise —%
- Apr 4, 2024Rating: TD Cowen · Buy → Buy
- Apr 9, 2024Downgrade: Piper Sandler · Overweight → Neutral
- May 7, 2024Earnings: -10.4; estimate -12; surprise 13.33%
- May 7, 2024Earnings: —; estimate -12; surprise —%
- May 22, 2024Downgrade: Jefferies · Buy → Hold
- Aug 8, 2024Earnings: -7.2; estimate -9.6; surprise 25%
- Aug 8, 2024Earnings: —; estimate -9.6; surprise —%
- Aug 13, 2024Downgrade: TD Cowen · Buy → Hold
- Aug 21, 2024Rating: Piper Sandler · Neutral → Neutral
- Nov 13, 2024Split: 1 for 40
- Nov 19, 2024Earnings: -0.24; estimate -8; surprise 97%
Signals (30)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Apr 2, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 18, 2025 | 1 year ago |
| RSI: Oversold | Mar 18, 2025 | 1 year ago |
| RSI: Oversold | Dec 12, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 3, 2024 | 1 year ago |
| RSI: Oversold | Nov 14, 2024 | 1 year ago |
| SMA: Bearish | Oct 29, 2024 | 2 years ago |
| SMA: Bullish | Oct 16, 2024 | 2 years ago |
| SMA: Bearish | Oct 15, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 14, 2024 | 2 years ago |
| SMA: Bullish | Sep 27, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 10, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 6, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 16, 2024 | 2 years ago |
| RSI: Oversold | Jul 30, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 24, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 11, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 2, 2024 | 2 years ago |
| SMA: Bearish | Jun 28, 2024 | 2 years ago |
| SMA: Bullish | Jun 27, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 24, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 17, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 12, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 6, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 25, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 27, 2024 | 2 years ago |
| SMA: Bearish | Mar 26, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 15, 2024 | 2 years ago |
| RSI: Overbought | Mar 6, 2024 | 2 years ago |
Key statistics
- Market cap
- 11.51M
- Enterprise value
- 402.97M
- Trailing P/E
- 0.00
- Forward P/E
- -8.11
- PEG ratio
- 0.00
- Price / sales
- 0.29
- Price / book
- 0.04
- EPS (TTM)
- -40.40
- Beta
- 1.63
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 39.74M
- Revenue growth
- -40.70%
- Free cash flow
- -15.76M
- Total cash
- 40.25M
- Total debt
- 419.07M
- Return on equity
- -45.90%
- Shares outstanding
- 3.02M
- Short % of float
- 18.96%
- 50-day average
- 9.50
- 200-day average
- 22.42
Analyst view
Consensus: hold
- Target (low)
- 4.00
- Target (mean)
- 4.67
- Target (high)
- 5.50
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell1
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate -7.10.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 19, 2024 | Sep 1, 2024 | -8.00 | -0.24 | +7.76 | +97.00% |
| Aug 8, 2024 | Jun 1, 2024 | -9.60 | -7.20 | +2.40 | +25.00% |
| Aug 8, 2024 | Jun 1, 2024 | -9.60 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | -12.00 | -10.40 | +1.60 | +13.33% |
| May 7, 2024 | Mar 1, 2024 | -12.00 | — | — | — |
| Mar 28, 2024 | Dec 1, 2023 | -15.60 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 2024 | Piper Sandler | main | Neutral | Neutral |
| Aug 13, 2024 | TD Cowen | down | Buy | Hold |
| May 22, 2024 | Jefferies | down | Buy | Hold |
| Apr 9, 2024 | Piper Sandler | down | Overweight | Neutral |
| Apr 4, 2024 | TD Cowen | main | Buy | Buy |
| Oct 11, 2023 | Piper Sandler | main | Overweight | Overweight |
About Danimer Scientific, Inc.
Danimer Scientific, Inc., a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company products are used in various applications, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Country
- United States
- Website
- danimerscientific.com
News
- Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace
- NYSE to Commence Delisting Proceedings Against Danimer Scientific, Inc. (DNMR)
- Danimer Scientific Takes Action to Strengthen Capital Structure
- TerraNova Capital Equities announces three transactions totaling $45 Million
- Danimer Scientific, Inc. (DNMR) Q3 2024 Earnings Call Transcript
- Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Tops Revenue Estimates
- Danimer Scientific Announces Third Quarter 2024 Results
- Earnings Scheduled For November 19, 2024
- Danimer Scientific Announces Release Date for Third Quarter 2024 Results
- Earnings Scheduled For November 14, 2024
Your note
Sign in to keep a note on DNMR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AMBOIAN JOHN P | Director | Conversion of Exercise of derivative security | May 30, 2024 | 936,436 |
| CALHOUN PHILIP GREGORY | Director | Conversion of Exercise of derivative security | May 30, 2024 | 3,801,910 |
| COHEN CYNTHIA R. | Director | Conversion of Exercise of derivative security | May 30, 2024 | 18,272 |
| HAJOST MICHAEL A. | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 6, 2024 | 71,064 |
| HENDRIX RICHARD J JR | Director | Conversion of Exercise of derivative security | May 30, 2024 | 459,596 |
| HUNT GREGORY WILLIAM | Director | Conversion of Exercise of derivative security | May 30, 2024 | 23,256 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 0.22% | 269,700 | 1.03M | Sep 29, 2024 |
| Vanguard Group Inc | 0.10% | 115,431 | 439.79K | Sep 29, 2024 |
| Invesco Ltd. | 0.04% | 48,816 | 185.99K | Sep 29, 2024 |
| Jefferies Financial Group Inc. | 0.04% | 47,982 | 182.81K | Sep 29, 2024 |
| Blackrock Inc. | 0.03% | 32,080 | 122.22K | Sep 29, 2024 |
| Millennium Management Llc | 0.03% | 34,563 | 131.69K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.06% | 73,111 | 278.55K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.03% | 31,401 | 119.64K | Sep 29, 2024 |
| Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 0.01% | 10,369 | 39.51K | Aug 30, 2024 |
| Invesco ETF Tr-Invesco FTSE RAFI US 1500 Small-Mid ETF | 0.01% | 9,305 | 35.45K | Sep 29, 2024 |
| Vanguard Materials Index Fund | 0.01% | 7,726 | 29.44K | Aug 30, 2024 |
| Fidelity Extended Market Index Fund | 0.01% | 15,206 | 57.93K | Oct 30, 2024 |